WO2001029232A3 - Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage - Google Patents

Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage Download PDF

Info

Publication number
WO2001029232A3
WO2001029232A3 PCT/US2000/028941 US0028941W WO0129232A3 WO 2001029232 A3 WO2001029232 A3 WO 2001029232A3 US 0028941 W US0028941 W US 0028941W WO 0129232 A3 WO0129232 A3 WO 0129232A3
Authority
WO
WIPO (PCT)
Prior art keywords
proteolytic cleavage
genes encoding
enzymes involved
encoding proteins
functional cloning
Prior art date
Application number
PCT/US2000/028941
Other languages
French (fr)
Other versions
WO2001029232A9 (en
WO2001029232A8 (en
WO2001029232A2 (en
Inventor
Barbara Cordell
Yonghong Li
Original Assignee
Scios Inc
Barbara Cordell
Yonghong Li
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scios Inc, Barbara Cordell, Yonghong Li filed Critical Scios Inc
Priority to AU13367/01A priority Critical patent/AU1336701A/en
Publication of WO2001029232A2 publication Critical patent/WO2001029232A2/en
Publication of WO2001029232A3 publication Critical patent/WO2001029232A3/en
Publication of WO2001029232A9 publication Critical patent/WO2001029232A9/en
Publication of WO2001029232A8 publication Critical patent/WO2001029232A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Abstract

This invention concerns methods and means for the functional cloning of genes encoding proteins or enzymes involved in proteolytic cleavage. The invention is based on the use of caspase expression cassettes comprising the coding sequence of a proteolytic cleavage site flanked by sequences encoding two caspase subunits.
PCT/US2000/028941 1999-10-20 2000-10-19 Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage WO2001029232A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU13367/01A AU1336701A (en) 1999-10-20 2000-10-19 Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16055999P 1999-10-20 1999-10-20
US60/160,559 1999-10-20
US22556400P 2000-08-14 2000-08-14
US60/225,564 2000-08-14

Publications (4)

Publication Number Publication Date
WO2001029232A2 WO2001029232A2 (en) 2001-04-26
WO2001029232A3 true WO2001029232A3 (en) 2002-03-21
WO2001029232A9 WO2001029232A9 (en) 2002-08-15
WO2001029232A8 WO2001029232A8 (en) 2003-10-23

Family

ID=26856991

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/028941 WO2001029232A2 (en) 1999-10-20 2000-10-19 Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage

Country Status (2)

Country Link
AU (1) AU1336701A (en)
WO (1) WO2001029232A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0517293D0 (en) * 2005-08-24 2005-10-05 Cancer Rec Tech Ltd Vectors and uses thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0691409A1 (en) * 1994-07-07 1996-01-10 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Modified proenzymes as substrates for proteolytic enzymes
WO1999035277A2 (en) * 1998-01-09 1999-07-15 Thomas Jefferson University Recombinant, active caspases and uses thereof
WO2000061768A2 (en) * 1999-04-13 2000-10-19 Yeda Research And Development Co. Ltd. Preparation of biologically active molecules

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0691409A1 (en) * 1994-07-07 1996-01-10 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Modified proenzymes as substrates for proteolytic enzymes
WO1999035277A2 (en) * 1998-01-09 1999-07-15 Thomas Jefferson University Recombinant, active caspases and uses thereof
WO2000061768A2 (en) * 1999-04-13 2000-10-19 Yeda Research And Development Co. Ltd. Preparation of biologically active molecules

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
COHEN G: "Caspase: the executioners of apoptosis", BIOCHEMICAL JOURNAL, PORTLAND PRESS, LONDON, GB, vol. 326, 15 August 1997 (1997-08-15), pages 1 - 16, XP002091927, ISSN: 0264-6021 *

Also Published As

Publication number Publication date
WO2001029232A9 (en) 2002-08-15
AU1336701A (en) 2001-04-30
WO2001029232A8 (en) 2003-10-23
WO2001029232A2 (en) 2001-04-26

Similar Documents

Publication Publication Date Title
RS50364B (en) Modified factor viii
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
GB0100551D0 (en) Protein
WO2000049158A3 (en) Psa and klk-2 splicing variants
WO2002060935A8 (en) A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences
EP0828003A3 (en) Human serine protease
WO1996024650A3 (en) Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences
AU2002225247A1 (en) The caveolin-1 gene and polypeptide encoded thereby and methods of use thereof
AUPP472398A0 (en) Protease susceptibility II
WO2002077241A3 (en) Isolated human metalloprotease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
WO2002026947A3 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
WO2001029232A8 (en) Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage
WO2002034922A3 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
WO2002042437A3 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
WO2001059120A3 (en) Il-17 like molecules and uses thereof
WO2001068846A3 (en) Transcription activator of the cited family
WO2002016566A3 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
WO2002046426A3 (en) Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
WO2002079228A3 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
WO2002079224A3 (en) Isolated human nadph oxidase, nucleic acid molecules encoding said proteins, and uses thereof
WO2001009292A3 (en) Sentrin-specific human proteases senp1-3
WO2002046378A3 (en) Alternative pol k nucleotide and amino acid sequence and methods for using
WO2002050286A3 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
WO2001092490A3 (en) Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof
WO1999057273A3 (en) Cytoplasmic antiproteinase-3 coding sequence in gene therapy

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/41-41/41, DRAWINGS, REPLACED BY NEW PAGES 1/41-41/41; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 17/2001 DUE TO A TECHNICAL PROBLEM AT THE TIME OF INTERNATIONAL PUBLICATION, SOME INFORMATION WAS MISSING (81). THE MISSING INFORMATION NOW APPEARS IN THE CORRECTED VERSION.

NENP Non-entry into the national phase

Ref country code: JP